1.3 General principles for treating people with stable angina 1.3.1 Do not exclude people with stable angina from treatment based on their age alone. 1.3.2 Do not investigate or treat symptoms of stable angina differently in men and women or in different ethnic groups. Preventing and treating episodes of angina 1.3.3 Offer a short-acting nitrate for preventing and treating episodes of angina. Advise people with stable angina: how to administer the short-acting nitrate to use it immediately before any planned exercise or exertion that side effects such as flushing, headache and light-headedness may occur to sit down or find something to hold on to if feeling light-headed. 1.3.4 When a short-acting nitrate is being used to treat episodes of angina, advise people: to repeat the dose after 5 minutes if the pain has not gone to call an emergency ambulance if the pain has not gone 5 minutes after taking a second dose. Drugs for secondary prevention of cardiovascular disease 1.3.5 Consider aspirin 75 mg daily for people with stable angina, taking into account the risk of bleeding and comorbidities. 1.3.6 Consider angiotensin-converting enzyme (ACE) inhibitors for people with stable angina and diabetes. Offer or continue ACE inhibitors for other conditions, in line with relevant NICE guidance. 1.3.7 Offer statin treatment in line with the NICE guideline on lipid modification. 1.3.8 Offer treatment for high blood pressure in line with the NICE guideline on hypertension. Dietary supplements 1.3.9 Do not offer vitamin or fish oil supplements to treat stable angina. Inform people that there is no evidence that they help stable angina. 1.4 Anti-anginal drug treatment General recommendations 1.4.1 Offer people optimal drug treatment for the initial management of stable angina. 